Cargando…

OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?

Brown adipose tissue (BAT) activation after cold exposure and its subsequent detection via18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is mediated through norepinephrine (NE) induced β3-adrenoceptor activation. Pheochromocytoma/paragangliomas (PPGLs), espe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Sater, Zahraa, Jha, Abhishek, Hamimi, Ahmed, Mandl, Adel, Hartley, Iris, Gubbi, Sriram, Gonzales, Melissa, Gharib, Ahmed, Pacak, Karel, Cypess, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555004/
http://dx.doi.org/10.1210/js.2019-OR29-6
_version_ 1783425071725936640
author Abdul Sater, Zahraa
Jha, Abhishek
Hamimi, Ahmed
Mandl, Adel
Hartley, Iris
Gubbi, Sriram
Gonzales, Melissa
Gharib, Ahmed
Pacak, Karel
Cypess, Aaron
author_facet Abdul Sater, Zahraa
Jha, Abhishek
Hamimi, Ahmed
Mandl, Adel
Hartley, Iris
Gubbi, Sriram
Gonzales, Melissa
Gharib, Ahmed
Pacak, Karel
Cypess, Aaron
author_sort Abdul Sater, Zahraa
collection PubMed
description Brown adipose tissue (BAT) activation after cold exposure and its subsequent detection via18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is mediated through norepinephrine (NE) induced β3-adrenoceptor activation. Pheochromocytoma/paragangliomas (PPGLs), especially SDH, VHL, and FH germline variants (cluster 1 tumors), predominantly secrete NE and often has higher maximal standardized uptake values of tumors on18F-FDG PET/CT(1). Therefore, 18F-FDG PET/CT scans of these NE-secreting PPGLs should also reveal higher BAT activity. Because BAT activation is also associated with cancer-induced cachexia and thus poor outcomes (2), BAT activation in PPGLs could also indicate aggressive tumor behavior. To study the relationship between BAT activation detected on 18F-FDG PET/CT and the clinical behavior of PPGLs, we performed a retrospective study of 343 patients with genetically characterized and histopathologically confirmed PPGLs who underwent 18F-FDG PET/CT imaging for disease surveillance between 2013 and 2017. After excluding patients with only post-operative PET scans and those with normal serum catecholamines and/or metanephrines, 205 patients were included in the final analysis. BAT activation was observed in 16 patients (7.8%; 28±17y; 10F/6M, 23.4±4.2 kg/m2). Hereditary PPGLs were present in 12/16 patients of which, 10 had cluster 1 variants (SDHx, n=7; HIF2A, n=2; VHL, n=1), 2 had cluster 2 variants (NF1, n=2), and 4 had sporadic PPGL. Elevated plasma biomarkers were as follows: epinephrine (n=0/16); metanephrine (n=2/16); NE (n=11/16); normetanephrine (n=16/16); and dopamine (n=8/16). A matched control group of 36 PPGL patients without detectable BAT activation (34±13y, 21F/15M,23.9±2.5 kg/m2, 12/36 SDHx, p=0.47) revealed a significantly lower mortality rate (n=2/36 vs n=4/16; p=0.043). All deaths in the BAT activation group were found in patients with SDHx variants compared to sporadic PPGL patients in the control group. The development of metastasis was similar in both groups (n=10/16, 62.5% vs. n=27/36, 75%; p=0.36). In conclusion, cluster 1 PPGLs are more likely to be associated with BAT activation. We show for the first time that particularly the combination of an SDHx mutation and BAT activation is associated with a higher mortality. Further investigation is necessary to establish the mechanistic connection between PPGLs, especially those with SDHx mutations, BAT activation, and poorer prognosis. References: 1-Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Current problems in cancer. 2014;38(1):7-41. 2-Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell metabolism. 2014;20(3):433-447.
format Online
Article
Text
id pubmed-6555004
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65550042019-06-13 OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign? Abdul Sater, Zahraa Jha, Abhishek Hamimi, Ahmed Mandl, Adel Hartley, Iris Gubbi, Sriram Gonzales, Melissa Gharib, Ahmed Pacak, Karel Cypess, Aaron J Endocr Soc Adrenal Brown adipose tissue (BAT) activation after cold exposure and its subsequent detection via18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is mediated through norepinephrine (NE) induced β3-adrenoceptor activation. Pheochromocytoma/paragangliomas (PPGLs), especially SDH, VHL, and FH germline variants (cluster 1 tumors), predominantly secrete NE and often has higher maximal standardized uptake values of tumors on18F-FDG PET/CT(1). Therefore, 18F-FDG PET/CT scans of these NE-secreting PPGLs should also reveal higher BAT activity. Because BAT activation is also associated with cancer-induced cachexia and thus poor outcomes (2), BAT activation in PPGLs could also indicate aggressive tumor behavior. To study the relationship between BAT activation detected on 18F-FDG PET/CT and the clinical behavior of PPGLs, we performed a retrospective study of 343 patients with genetically characterized and histopathologically confirmed PPGLs who underwent 18F-FDG PET/CT imaging for disease surveillance between 2013 and 2017. After excluding patients with only post-operative PET scans and those with normal serum catecholamines and/or metanephrines, 205 patients were included in the final analysis. BAT activation was observed in 16 patients (7.8%; 28±17y; 10F/6M, 23.4±4.2 kg/m2). Hereditary PPGLs were present in 12/16 patients of which, 10 had cluster 1 variants (SDHx, n=7; HIF2A, n=2; VHL, n=1), 2 had cluster 2 variants (NF1, n=2), and 4 had sporadic PPGL. Elevated plasma biomarkers were as follows: epinephrine (n=0/16); metanephrine (n=2/16); NE (n=11/16); normetanephrine (n=16/16); and dopamine (n=8/16). A matched control group of 36 PPGL patients without detectable BAT activation (34±13y, 21F/15M,23.9±2.5 kg/m2, 12/36 SDHx, p=0.47) revealed a significantly lower mortality rate (n=2/36 vs n=4/16; p=0.043). All deaths in the BAT activation group were found in patients with SDHx variants compared to sporadic PPGL patients in the control group. The development of metastasis was similar in both groups (n=10/16, 62.5% vs. n=27/36, 75%; p=0.36). In conclusion, cluster 1 PPGLs are more likely to be associated with BAT activation. We show for the first time that particularly the combination of an SDHx mutation and BAT activation is associated with a higher mortality. Further investigation is necessary to establish the mechanistic connection between PPGLs, especially those with SDHx mutations, BAT activation, and poorer prognosis. References: 1-Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Current problems in cancer. 2014;38(1):7-41. 2-Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell metabolism. 2014;20(3):433-447. Endocrine Society 2019-04-30 /pmc/articles/PMC6555004/ http://dx.doi.org/10.1210/js.2019-OR29-6 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Adrenal
Abdul Sater, Zahraa
Jha, Abhishek
Hamimi, Ahmed
Mandl, Adel
Hartley, Iris
Gubbi, Sriram
Gonzales, Melissa
Gharib, Ahmed
Pacak, Karel
Cypess, Aaron
OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
title OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
title_full OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
title_fullStr OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
title_full_unstemmed OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
title_short OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
title_sort or29-6 brown adipose tissue activation in sdhx-related pheochromocytoma and paraganglioma: an ominous sign?
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555004/
http://dx.doi.org/10.1210/js.2019-OR29-6
work_keys_str_mv AT abdulsaterzahraa or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT jhaabhishek or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT hamimiahmed or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT mandladel or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT hartleyiris or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT gubbisriram or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT gonzalesmelissa or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT gharibahmed or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT pacakkarel or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign
AT cypessaaron or296brownadiposetissueactivationinsdhxrelatedpheochromocytomaandparagangliomaanominoussign